Global Neuromodulation Devices Market Set to Double by 2030: Spinal Cord Stimulation (SCS) Applications Dominate
May 14, 2024 09:36 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By...
Finnish Hospital Orders Nexstim NBS System 5
May 08, 2024 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 8 May 2024 at 9 AM (EEST) Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a...
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
February 27, 2024 09:00 ET
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Neuromodulation Market is Expected to Reach $11.0 Billion | MarketsandMarkets™
February 22, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Neuromodulation market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR...
Neuromodulation Devices Market Report 2024-2034: Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation
February 12, 2024 04:37 ET
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.Revenue for the neuromodulation devices market is...
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET
|
Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
January 18, 2024 08:00 ET
|
Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
Global Neuromodulation Devices Markets, 2021-2027 with 2023 as the Base Year - Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements
October 13, 2023 06:13 ET
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Devices Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.This research service analyzes the...
Global Neuromodulation Strategic Research Report 2023: Market to Reach $11.6 Billion by 2030 - Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
September 29, 2023 04:13 ET
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Neuromodulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Neuromodulation Market to Reach...
Neuromodulation Market is estimated to be US$ 12.23 billion by 2030 with a CAGR of 8.9% during the forecast period – By PMI
September 28, 2023 13:00 ET
|
PMI
Covina, Sept. 28, 2023 (GLOBE NEWSWIRE) -- What is Neuromodulation? Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of...